The most valuable data for medical research is often the hardest to use. It sits in hospital servers, siloed by patient privacy laws, incompatible formats, and institutional caution. For a researcher studying a rare disease or a developer training a clinical AI, assembling a statistically significant dataset can take years of permissions and manual curation. Agora Labs, a Rome-based startup founded in 2022, is betting that the answer isn't to centralize this data, but to leave it exactly where it is. The company installs a physical computing node inside a hospital's own infrastructure, powered by Nvidia GPUs, that structures and anonymizes patient records on-site. Only then is the processed data made available for external research queries, creating what the company calls a federated network where the raw information never leaves the building [Startupbusiness.it, October 2026].
The Architecture of Trust
Agora's product is a response to a regulatory reality, not just a technical challenge. The company emerged from a European research project on secure clinical-data sharing that launched after the EU's General Data Protection Regulation (GDPR) took effect in 2018 [Startupbusiness.it, October 2026]. Its architecture is designed to navigate this landscape. A hospital installs an "Agora Node," an on-premises server that uses specialized large language models to standardize messy, unstructured clinical notes into a research-ready format. The system then applies what the company describes as irreversible mathematical anonymization to the data. This process, which happens before any data is shared, is the core of its privacy guarantee. Researchers and pharmaceutical companies can query the federated network for real-world evidence, but they receive aggregated, anonymized insights, not individual patient records [Startupbusiness.it, October 2026]. The model is business-to-business, with hospitals as the paying customers who gain a new, compliant revenue stream from their data assets.
The Team and the Traction
The founding team blends deep clinical experience with technical and commercial rigor. CEO Davide Zaccagnini is a vascular surgeon and a biomedical computer scientist trained at MIT [Startupbusiness.it, October 2026]. His co-founder, Fabio Giulietto, is an engineer with an MBA from Imperial College London [Forbes Italia, October 2026]. This combination speaks directly to the problem: Zaccagnini understands the hospital workflow and the sanctity of the patient record, while Giulietto oversees the scalable engineering required to deploy across institutions. Their early traction suggests the thesis is resonating. The company reports a network of 50 international healthcare institutions, including prestigious names like Harvard Medical School and San Raffaele Hospital in Milan [Forbes Italia, October 2026]. In October 2026, Agora Labs secured a €4.3 million (approximately $4.6 million) seed round led by Italian venture firm P101, with participation from the Mussetto family's Infinite Five holding company [Forbes Italia, October 2026]. The capital is earmarked for growth, with plans to double its hospital network in the following months [Forbes Italia, October 2026].
Seed Round (Oct 2026) | 4.6 | M USD
Navigating a Crowded and Cautious Field
The ambition is significant, but the path is lined with formidable challenges. Agora Labs operates in the competitive real-world evidence market, where large established players like IQVIA and Flatiron Health have deep relationships and massive aggregated datasets. Its differentiation rests on the federated, privacy-by-design model, which may appeal to European institutions particularly wary of data transfer. However, adoption requires hospitals to make a substantial technical and procedural commitment. Installing on-premise hardware and integrating with legacy hospital IT systems is a complex, slow sales motion. The company must also continuously prove that its anonymization techniques are robust enough to withstand evolving re-identification attacks and satisfy diverse international regulators beyond GDPR. The open roles on its careers page, which include a senior privacy engineer and a software engineer, indicate a focus on strengthening these core technical and compliance foundations [agoralabs.eu/work-with-us, retrieved 2024].
The Next Twelve Months
The coming year will be a critical test of scalability and product-market fit. The key metrics to watch are not just the count of new hospital nodes installed, but evidence of active research utilization across the network. Success will be measured by the volume and value of research queries processed and the renewal and expansion of contracts with initial partners like Harvard and San Raffaele. The company must also demonstrate that its platform can support a diverse range of research, from retrospective observational studies to prospective trials for drug developers. A successful Series A round would likely hinge on showing that this federated model can become a new standard for ethical data collaboration, rather than a niche solution.
The patient population at the heart of this endeavor is broad. It encompasses anyone whose treatment history, locked in a digital hospital record, could help answer a critical research question for conditions like cardiovascular disease, cancer, or rare genetic disorders. The standard of care today for using this data is often a fragmented, manual process. A researcher might spend months negotiating data-use agreements, then receive a static, de-identified dataset that is already out of date. Agora Labs is proposing a live, queryable network that keeps pace with clinical practice. If it works, the hope is that breakthroughs in medicine won't have to wait for the data to catch up.
Sources
- [Forbes Italia, October 2026] Agora Labs raccoglie 4,3 milioni per mettere i dati clinici a disposizione della ricerca (in forma anonima) | https://forbes.it/2026/10/27/agora-labs-43-milioni-mettere-dati-clinici-disposizione-ricerca/
- [Startupbusiness.it, October 2026] P101 leads the €4.3 million funding round in Agora Labs | https://www.startupbusiness.it/en/p101-leads-the-e4-3-million-funding-round-in-agora-labs/211391/
- [agoralabs.eu/work-with-us, retrieved 2024] Agora Labs Careers Page | https://www.agoralabs.eu/work-with-us